שיטות טיפול באמצעות מעכבי bcl–2 סלקטיביים

• 收藏
• 分享

专利权人:

ABBVIE IRELAND UNLIMITED COMPANY

发明人:

申请号：

IL25184517

公开号：

IL251845D0

申请日:

2017.04.20

申请国别(地区):

IL

年份:

2017

代理人:

摘要：

This invention pertains to methods of treating systemic lupus erythematosus, lupus nephritis or Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl-2 anti-apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl-x L .

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/